TMO Thermo Fisher Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TMO

Price (delayed)

$457.96

Market cap

$170.19B

P/E Ratio

25.14

Dividend/share

$1.8

EPS

$18.22

Enterprise value

$210.09B

?
Relative Growth: Rel. Growth: 47
Relative Strength: Rel. Strength: 39
Relative Valuation: Rel. Valuation: 45
Relative Profitability: Rel. Profitability: 68

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
The stock's price to earnings (P/E) is 17% less than its 5-year quarterly average of 31.1 and 4.6% less than its last 4 quarters average of 27.2
TMO's EPS is up by 7% year-on-year and by 2.5% since the previous quarter
The company's equity rose by 5% YoY but it fell by 2.8% QoQ
Thermo Fisher Scientific's quick ratio has decreased by 32% from the previous quarter and by 22% YoY
The debt has increased by 26% YoY and by 10% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.thermofisher.com/
Peers: BDX WAT BIO ISRG

Key stats

What are the main financial stats of TMO

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
-3.1%
1 week
-5%
1 month
4.48%
1 year
17.35%
YTD
-20.97%
QTD
-6.83%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$45.2B
Gross profit
$18.43B
Operating income
$7.9B
Net income
$6.85B
Gross margin
40.8%
Net margin
15.2%
The operating income has grown by 7% YoY
Thermo Fisher Scientific's revenue has increased by 5% YoY
Thermo Fisher Scientific's net income has increased by 5% YoY and by 2.1% from the previous quarter
Thermo Fisher Scientific's gross profit has increased by 4% YoY

Price vs fundamentals

How does TMO's price correlate with its fundamentals

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
TMO P/E details
P/E
25.14
P/B
3.28
P/S
3.77
EV/EBIT
23.77
EV/EBITDA
18.03
EV/Sales
4.65
The stock's price to earnings (P/E) is 17% less than its 5-year quarterly average of 31.1 and 4.6% less than its last 4 quarters average of 27.2
TMO's EPS is up by 7% year-on-year and by 2.5% since the previous quarter
The P/B is 27% below the 5-year quarterly average of 4.6 and 3.4% below the last 4 quarters average of 3.5
The company's equity rose by 5% YoY but it fell by 2.8% QoQ
The P/S is 21% below the 5-year quarterly average of 4.9 and 5% below the last 4 quarters average of 4.1
Thermo Fisher Scientific's revenue has increased by 5% YoY

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's return on invested capital is down by 6% year-on-year and by 2.6% since the previous quarter
TMO's ROA is down by 3% YoY

Dividends

What is TMO's dividend history
Dividend details
DPS
$1.8
Dividend yield
0.39%
Payout ratio
9.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 85% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has decreased by 32% from the previous quarter and by 22% YoY
Thermo Fisher Scientific's total liabilities has increased by 23% YoY and by 8% from the previous quarter
The debt is 17% lower than the equity
The debt has increased by 26% YoY and by 10% QoQ
Thermo Fisher Scientific's debt to equity has increased by 20% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.